Pharmafile Logo
Pharmafocus logo
Advanced Search

genomics

Showing 6 posts of 21 posts found.

Novartis eyes genomics route for flu vaccines

October 11, 2010
Manufacturing and Production, Research and Development Novartis, Synthetic Genomics Vaccines, genomics

Novartis will make use of a technology developed by Synthetic Genomics Vaccines, a new company set up by genomics pioneer …

News

Sanofi signs personalised medicine alliance

August 11, 2010
Research and Development Sanofi-Aventis, Scripps Genomic Medicine, genomics

Sanofi-Aventis has signed a personalised medicine research alliance with US not-for-profit company Scripps Genomic Medicine. The company is part of …

News
Wellcome Trust Sanger Institute

Study boost for personalised cancer treatments

July 23, 2010
Research and Development Cancer, genome, genomics, personalised medicine

A five-year study by scientists in the UK and US of the way genomes and cancer medicines interact has yielded …

News

Huge drug discovery database launched

January 26, 2010
Research and Development ChEMBLdb, Wellcome, genome, genomics

A huge online database of information on the properties and activities of drugs and drug-like small molecules and their targets …

News

Roche invests in Spanish genome project

November 27, 2009
Research and Development Roche, Spain, genomics

Roche is investing in a Spanish health authority programme to analyse the genomes of people with rare diseases.The pharma company …

News

Roche divests protein expression portfolio

September 10, 2009
Research and Development Roche, genomics

 Roche has sold its cell-free protein expression kits business for an undisclosed sum.Berlin-based company RiNA will take control of the …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024